Cancer stem cells: implications for the progression and treatment of metastatic disease

AK Croker, AL Allan - Journal of cellular and molecular …, 2008 - Wiley Online Library
• Introduction• The metastatic process‐Metastatic inefficiency‐Organ‐specific metastasis:
seed and soil‐Epithelial‐mesenchymal transition (EMT)• The cancer stem cell hypothesis …

[HTML][HTML] Dual effect of oxidative stress on leukemia cancer induction and treatment

UK Udensi, PB Tchounwou - Journal of Experimental & Clinical Cancer …, 2014 - Springer
Oxidative stress (OS) has been characterized by an imbalance between the production of
reactive oxygen species (ROS) and a biological system's ability to repair oxidative damage …

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

V Mathews, B George, KM Lakshmi, A Viswabandya… - Blood, 2006 - ashpublications.org
Arsenic trioxide, as a single agent, has proven efficacy in inducing molecular remission in
patients with acute promyelocytic leukemia (APL). There is limited long-term outcome data …

Differentiation therapy of human cancer: basic science and clinical applications

M Leszczyniecka, T Roberts, P Dent, S Grant… - Pharmacology & …, 2001 - Elsevier
Current cancer therapies are highly toxic and often nonspecific. A potentially less toxic
approach to treating this prevalent disease employs agents that modify cancer cell …

Retinoids in chemoprevention and differentiation therapy

LA Hansen, CC Sigman, F Andreola, SA Ross… - …, 2000 - academic.oup.com
Retinoids are essential for the maintenance of epithelial differentiation. As such, they play a
fundamental role in chemoprevention of epithelial carcinogenesis and in differentiation …

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor α in acute promyelocytic-like leukaemia

C Arnould, C Philippe, V Bourdon… - Human molecular …, 1999 - academic.oup.com
Acute promyelocytic leukaemia (APL) exhibits a characteristic t (15; 17) translocation that
fuses the promyelocytic leukaemia (PML) gene on 15q22 to the retinoic acid receptor α …

Therapy of molecular relapse in acute promyelocytic leukemia

FL Coco, D Diverio, G Avvisati, MC Petti… - Blood, The Journal …, 1999 - ashpublications.org
Fourteen patients with PML/RAR-positive acute promyelocytic leukemia (APL) were given
salvage therapy at the time of first molecular relapse. All patients had achieved first …

Adult acute myeloid leukaemia

M Smith, M Barnett, R Bassan, G Gatta… - Critical reviews in …, 2004 - Elsevier
The curability of acute myeloid leukaemia (AML) in a fraction of adult patients was
demonstrated a long time ago. Currently, the probability of cure is consistently above fifty per …

Prognostic impact of acute myeloid leukemia classification: importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival

DA Arber, AS Stein, NH Carter, D Ikle… - American journal of …, 2003 - academic.oup.com
To evaluate the prognostic impact of acute myeloid leukemia (AML) classifications,
specimens from 300 patients with 20% or more bone marrow myeloblast cells were studied …

Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate

R Ohno, N Asou, K Ohnishi - Leukemia, 2003 - nature.com
Acute promyelocytic leukemia (APL) has become a curable disease by all-trans retinoic acid
(ATRA)-based induction therapy followed by two or three courses of consolidation …